Prostate cancer transfection by acoustic energy using pEGFP-N1 as reporter gene in the solid Dunning R-3327-MatLu tumor

Prostate Cancer and Prostatic Diseases

Volumn 6, Issue 4, 2003, Pages 290-293

  Michel, Maurice Stephen ^a   Erben, P ^a   Trojan, L ^a   Knoll, T ^a   Alken, P ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Acoustic energy; Gene therapy; Transfection

Indexed keywords

DNA; PLASMID DNA; PRODRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CANCER MODEL; CANCER TRANSPLANTATION; CONTROLLED STUDY; DNA TRANSFECTION; FLUORESCENCE ACTIVATED CELL SORTING; GENE THERAPY; GENETIC TRANSFECTION; NONHUMAN; ONCOLOGICAL PARAMETERS; PRIORITY JOURNAL; PROSTATE CANCER; RAT; REPORTER GENE; SHOCK WAVE; SUICIDE GENE THERAPY;

ACOUSTICS; ANIMALS; CELL LINE, TUMOR; ELECTROMAGNETICS; GENES, REPORTER; MALE; NEOPLASM TRANSPLANTATION; PROSTATIC NEOPLASMS; RADIATION; RATS; TRANSFECTION;

EID: 0346460012     PISSN: 13657852     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.pcan.4500667     Document Type: Article

References (15)

1. Verma I, Somia N, Gene therapy - promises, problems and prospects. Nature 1997; 389: 239-242.
2. Doehmer J et al. Introduction of rat growth hormone gene into mouse fibroblasts via a retroviral DNA vector: expression and regulation. Proc Natl Acad Sci USA 1982; 79: 2268-2272.
3. Lohr F et al. Effective tumor therapy with plasmid-encoded cytokines combined with in vivo electroporation. Cancer Res 2001; 61: 3281-3284.
4. Capecchi MR. High efficiency transformation by direct microinjection of DNA into cultured mammalian cells. Cell 1980; 22: 479-488.
5. Gambihler S, Delius M, Ellwart JW. Permeabilization of the plasma membrane of L1210 mouse leukaemia cells using lithotripter shock waves. J Membr Biol 1994; 141: 267-275.
6. Miller N, Vile R. Targeted vectors for gene therapy. FASEB J 1995; 9: 190-199.
7. Lauer U et al. Shock waves permeabilization as a new gene transfer method. Gene Therapy 1997; 4: 710-715.
8. Bao S, Thrall BD, Miller DL. Transfection of a reporter plasmid into cultured cells by sonoporation in vitro. Ultrasound Med Biol 1997; 23: 953-959.
9. Michel MS, Köhrmann KU, Siegsmund M, Alken P. Acoustic energy for genomic engineering of prostate cancer cells. BJU Int 2000; 86(Suppl 3): 151.
10. Delagrave S et al. Red-shifted excitation mutants of the green fluorescent protein. Biotechnology 1995; 13: 151-154.
11. Shirakawa T et al. Tissue-specific promoters in gene therapy for the treatment of prostate cancer. Mol Urol 2000; 4: 73-82.
12. Thompson TC. In situ gene therapy for prostate cancer. Oncol Res 1999; 11: 1-8.
13. Voeks D et al. Gene therapy for prostate cancer delivered by ovine adenovirus and mediated by purine nucleoside phosphorylase and fludarabine in mouse models. Gene Therapy 2002; 9: 759-768.
14. Palapattu GS, Naitoh J, Belldegrun AS. Gene therapy for prostate cancer. New perspectives on an old problem. Urol Clin N Am 1999; 26: 353-363.
15. Fiedler M et al. Immunization of woodchucks (Marmota monax) with hepatitis delta virus DNA vaccine. Vaccine 2001; 19: 4618-4626.